Assert-IQ ICM

Designed to Outperform, Built to Outlast

Our state-of-the-art insertable cardiac monitor (ICM) sets a new standard for continuous monitoring and automatic arrhythmia detection. Assert-IQ ICM is the longest lasting Bluetooth® ICM,1-8 that provides true value with reduced false positives, simplified clinic workflows, and reduced data burden9-12 – all within a small device that integrates seamlessly into patients’ lives.

Longest Lasting Bluetooth® ICM

Building on a reputation for innovation, Assert-IQ is the longest lasting Bluetooth®-enabled ICM that operates at full functionality beyond six years with no compromises.1-8,14

gradient background

Clear, Crisp EGMs

With Assert-IQ ICM, you can expect to get clear, crisp EGMs for improved visualization of P-waves, which could lead to a faster care decision for your patients.14

Data Burden

Advanced algorithms assist in reducing clinic data while maintaining sensitivity to detect true events. Designed to build user confidence and provide reassurance to your patients, the algorithm enhancements have been proven to reduce false detection and data burden as shown below:

Assert-IQ ICM’s advanced algorithms reduce false detections by 98.7% for AF and Pause, while maintaining 97.7% of true EGMs.9,10

98.7%

When compared to the latest version of LINQ II,
Assert-IQ ICM’s AF algorithm reduces data burden by 21% while maintaining sensitivity.*,9,15,16

New IQ Insights

Assert-IQ ICM provides a holistic view of cardiovascular health with new IQ Insights that show trends and timelines to empower data-driven decisions.

Premature Ventricular Contractions (PVCs)
Leading PVC detection algorithm offers the ability to capture consecutive events, including couplets and triplets.18

PVC heart

Elevated Heart Rate with and without Activity
An ICM first.1-8

running icon

Body Position & Posture Changes
Assess patient factors to help adjudicate episodes.

laying in bed icon

DirectTrend™ Viewer
Assess AF Burden, PVCs, Activity Trends, and MORE!

DirectTrend Viewer icon
gradient background

Key Episodes**—Optimized for Each Arrhythmia Type

While other devices use a standard set of criteria for all types of arrhythmias, Assert-IQ ICM uses Key Episode** technology that tailors data to the arrhythmia type. This technology gives you the flexibility to toggle between viewing all episodes or 3 Key Episodes** that are most critical to your patient’s care.

Assert-IQ ICM empowers you and your clinic to take a more personalized approach to patient management with valuable insights designed to help inform treatment decisions.
 

 Assert-IQ™ ICMMedtronic
Reveal LINQ
Medtronic
LINQ II
Arrhythmia TypeKey Episode Selection:
Up to 3 EGMs per day,
per arrhythmia type1
Selection: One EGM
per day based on wireless
data priority2
Selection: Three
auto episode EGMs per
day per arrhythmia type3
Atrial Fibrillation 

1. Longest episode
2. Second longest episode
3. Fastest mean rate

One EGM per
day sent wirelessly 

Patient manual
transmission optional to
see all information2

Same standard criteria set
for all arrhythmia types

1. First episode
2. Second episode
3. Longest episode

Tachycardia

1. Longest episode
2. Second longest episode
3. Fastest maximum rate

Bradycardia 

1. Longest episode
2. Second longest episode
3. Fastest minimum rate

Pause 

1. Longest episode
2. Second longest episode
3. Shortest episode

Watch the Assert-IQ ICM Insertion Procedure

References

 As of 12.31.23. Reveal LINQ User Manual, LUX-Dx User Manual, LUX-Dx II/II+ User Manual, BIOMONITOR III User Manual, BIOMONITOR IIIm User Manual, and BIOMONITOR IV User Manual.

*As of 12.31.22, LINQ II‡ with AccuRhythm AI. EGM burden comparison is based on two independent, random, real-world data sets. Patient characteristics and device programming may differ.

** Key Episodes is a feature of Merlin.net™ PCN

  1. Abbott. Assert-IQ ICM User Manual.
  2. Medtronic. REVEAL LINQ‡ LNQ11 Insertable Cardiac Monitor and Patient Assistant PA96000 Clinician Manual. Updated January 25, 2022. Accessed February 23, 2024. https://www.medtronic.com/content/dam/emanuals/crdm/M027641C001B_view.pdf
  3. Medtronic. LINQ II‡ LNQ22 Insertable Cardiac Monitor Clinician Manual. Updated October 11, 2022. Accessed February 23, 2024. https://www.medtronic.com/content/dam/emanuals/crdm/M027638C001B_view.pdf
  4. Boston Scientific. User’s Manual, LUX-Dx‡ Insertable Cardiac Monitor System M301, 2925, 2935. Updated May 2022. Accessed February 23, 2024. https://www.bostonscientific.com/content/dam/elabeling/crm/92216690-006_LUX-Dx_ICM_UM_es_S.pdf
  5. Boston Scientific. User’s Manual, LUX-Dx II/II+‡ Insertable Cardiac Monitor System M302, M312, 2925, 2929, 2935, 2939. Updated August 2023. Accessed February 23, 2024. https://www.bostonscientific.com/content/dam/elabeling/crm/51583079-001_LUX-Dx_ICM_UM_en_S.pdf
  6. Biotronik. Technical Manual BIOMONITOR III‡. Updated March 22, 2023. Accessed February 23, 2024. https://manuals.biotronik.com/emanuals-professionals/?country=ES&product=ImplCardMon/BioMonitor3/BioMonitor3
  7. Biotronik. Technical Manual BIOMONITOR IIIm‡. Updated March 22, 2023. Accessed February 23, 2024. https://manuals.biotronik.com/emanuals-professionals/?country=ES&product=ImplCardMon/BioMonitor3m/BioMonitor3m
  8. Biotronik. Technical Manual BIOMONITOR IV‡. Updated December 06, 2023. Accessed February 23, 2024. https://manuals.biotronik.com/emanuals-professionals/?country=ES&product=ImplCardMon/BioMonitor4/BioMonitor4
  9. Gopinathannair R, Shehata MM, Afzal MR, et al. Novel Algorithms Improve Arrhythmia Detection Accuracy in Insertable Cardiac Monitors. Journal of Cardiovascular Electrophysiology. 2023;34(9):1961-1968. doi:10.1111/jce.16007
  10. Data on File. Abbott - Report SJM-CFM-0919-0163.
  11. Shehata MM, Manyam H, Gopinathannair R, et al. Evaluating the Impact of New Arrhythmia Detection Algorithms in an lnsertable Cardiac Monitor. Presented at: Asia Pacific Heart Rhythm Society (APHRS); November 18-20, 2022; Singapore.
  12. Gardner RS, Quartieri F, Betts TR, et al. Reducing the Electrogram Review Burden Imposed by Insertable Cardiac Monitors. Journal of Cardiovascular Electrophysiology. 2022;33(4):741-750. doi:10.1111/jce.15397
  13. Data on File. Abbott - Report 90984075.
  14. Shehata MM, Nair DG, Qu F, et al. Insertable Cardiac Monitor P-wave Visibility in a New Clinical Report. Presented at Asia Pacific Heart Rhythm Society (APHRS); Bangkok Thailand; 2022.
  15. Radtke, et al. Artificial Intelligence Enables Dramatic Reduction of False Atrial Fibrillation Alerts from Insertable Cardiac Monitors. Presented at Heart Rhythm Society (HRS); Boston, USA; Aug 2021.
  16. Data on File. Abbott - Report 90986479A; AF EGM Burden Reduction in Assert-IQ ICM.
  17. Manyam H, Afzal MR, Gopinathannair R, et al. Evaluation of A Novel Premature Ventricular Contraction Detection Algorithm in an Insertable Cardiac Monitor. Presented at Heart Rhythm Society (HRS); San Francisco, USA; 2022.

™ Indicates a trademark of the Abbott group of companies.

Indicates a third -party trademark, which is property of its respective owner.

Bluetooth and Bluetooth logo are registered trademarks of Bluetooth SIG, Inc.

Additional references

  1. Medtronic. LINQ II LNQ22 Insertable Cardiac Monitor Clinician Manual. Updated October 11, 2022. Accessed February 23, 2024.  https://www.medtronic.com/content/dam/emanuals/crdm/M027638C001B_view.pdf
  2. Boston Scientific. User’s Manual, LUX-Dx Insertable Cardiac Monitor System M301, 2925, 2935. Updated May 2022. Accessed February 23, 2024. https://www.bostonscientific.com/content/dam/elabeling/crm/92216690-006_LUX-Dx_ICM_UM_es_S.pdf
  3. Boston Scientific. User’s Manual, LUX-Dx II/II+ Insertable Cardiac Monitor System M302, M312, 2925, 2929, 2935, 2939. Updated August 2023. Accessed February 23, 2024. https://www.bostonscientific.com/content/dam/elabeling/crm/51583079-001_LUX-Dx_ICM_UM_en_S.pdf

MAT-2403091 v2.0